PM Magazine

PMcardio Expands AI-Powered ECG Solution to Telemedicine for Pharmacy and Primary Care-Based Patient Screening

PMcardio, an AI-driven, CE-certified class (II)b medical device developed by Powerful Medical, is now supporting telemedicine workflows to enhance ECG analysis and diagnosis for patients outside traditional hospital settings.

Editor's Choice

Powerful Medical at AHA 2024: Leading the Way in AI-driven Cardiac Care

Timothy D. Henry, MD joins Powerful Medical's US Scientific board

Timothy D. Henry, MD Joins Powerful Medical’s US Scientific Advisory Board Amidst Entry to the US Market

Jolimont Hospital Helora

Jolimont Hospital in Belgium Implements PMcardio AI to Detect Acute Myocardial Infarction

Dr. Joseph Banno

Dr. Banno Pins Down Subtle STEMI Case Using PMcardio’s OMI AI Model

aha24sumblogcvr

PMcardio Steals the Show at AHA 2024, Demonstrating High Accuracy with 5 Clinical Validation Studies

The American Heart Association (AHA) conference is one of the most anticipated cardiology events in the world, bringing together 15,000 to 18,000 attendees each year—from trailblazing researchers to frontline clinicians and innovators shaping the future of heart health.
Left Ventricular Systolic Dysfunction (LVSD) (2)

Left Ventricular Systolic Dysfunction: The Basics and AI Advancements in Detection

In this comprehensive article, we delve into the intricacies of Left Ventricular Systolic Dysfunction (LVSD), thoroughly analyzing its symptoms, causes, and severity. We explore the latest advancements in diagnostic tools and real-world case studies.

Women’s Health and Cardiac Care: A Call to Action for Healthcare Providers

Healthcare providers are dedicated to delivering equitable and effective care to all patients. However, historical biases and gaps in medical research have led to disparities in how we diagnose and treat diseases across different groups.

Advancing Clinical Research: The Current Stage of Powerful Medical’s OMI AI ECG Model Validation Pipeline

At Powerful Medical, we are deeply engaged in enhancing and rigorously validating our OMI AI ECG Model, which is now undergoing extensive testing at 32 clinical sites globally.

Stay on the pulse with our newsletter

Your submission was successful